2014 in review

The WordPress.com stats helper monkeys prepared a 2014 annual report for this blog.

Here’s an excerpt:

The concert hall at the Sydney Opera House holds 2,700 people. This blog was viewed about 40,000 times in 2014. If it were a concert at Sydney Opera House, it would take about 15 sold-out performances for that many people to see it.

Click here to see the complete report.

Escaping the Shadow

The holiday season can be difficult for cancer patients and their loved ones. It’s tough to be merry while dealing with treatment side effects or wondering whether one will be alive this time next year.
By the end of November this year, I’d hit a low point. My energy had waned, oppressed by the shorter days and gray skies of Seattle and a general sense of ill health. My cough had increased, stirring fears of recurrence. My writing muse had burned out after weeks of intensive Lung Cancer Awareness Month activities.

Then, within one week, two lung cancer buddies died, and a third friend died of metastatic breast cancer days after being diagnosed. I kept vigil with her family as her lungs failed from obstructive pneumonia–a scenario that was far too familiar. The shadow of my own Ghost of Christmas Future loomed, and holiday lights did nothing to brighten it.

In a rare moment of prescience last summer, my family had planned the perfect remedy for me … read more on my Cure Today blog

Club Regina balcony view

Image credit:
Creative Commons License
JFD20141220-CancunClubRegina by Janet Freeman-Daily is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Lessons Learned on a Yucatán Vacation

Tulum ruins and beach

  • Arriving at the Cancun airport requires tolerance for chaos.  On the other hand, it’s a great place to meet persuasive people who want to take you places.
  • Treat all red octagonal “ALTO” road signs as recommendations.
  • Hearing “Have Yourself a Merry Little Christmas” simultaneously with the pounding of ocean surf on fine sand creates serious cognitive dissonance.
  •  (air conditioning)+(incomplete door seal)+(tropical thunderstorm) = damp musty bedding
  • 92% relative humidity leaves fascinating streaks in excess sunscreen.
  • Uncontrolled experiments prove UBF50 swimwear protects you longer in the ocean than the waterproof sunscreen you put on your face.
  • Standing in the surf provides a feast of sensory delights — if you keep your mouth shut.
  • White sand beaches migrate into hotel rooms.
  • A Spanish-English dictionary app radically reduces time spent ordering and shopping for food.
  • When boiling tap water for drinking the next morning, the kitchen timer is your friend.
  • Tropical tours that depart early in the morning will reduce exposure to heat and cheap souvenirs.
  • Lisa Simpson becomes an alto in Spanish. That’s just wrong.
  • According to my blistered toes, those newly-rediscovered sandals I packed were lost for a reason.
  • Every breakfast buffet should feature chocolate sauce for omelets.
  • Departing from the Cancun airport requires running an upscale shopping gauntlet.
  • Ending a tropical vacation with an aerial view of the Northern Lights is pure awesomeness.

Image credit: Creative Commons License
Tulum Ruins and Beach by Janet Freeman-Daily is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Joe Cocker Dies from Lung Cancer

Although I’m saddened by his death, I’m glad Joe Cocker’s obituary stated lung cancer as the cause of death. Only when prominent people are brave enough to admit they have lung cancer (despite the stigma) will the public realize the prevalence of the biggest cancer killer. All you need to get lung cancer are lungs.

RIP, Joe.

Stanford Scope blog: Lung Cancer Social Media contributions to my Medicine X speech

This is a reblog of my post that appeared in the on the Stanford Scope Blog on November 17, 2014


Tackling the stigma of lung cancer — and showing the real faces of the disease


When I first learned I would be giving an ePatient Ignite! talk at Stanford’s Medicine X, I knew I wanted to speak about the stigma of lung cancer. I had frequently heard the first question typically asked of lung cancer patients – “Did you smoke?” – and I wanted to help change public perception of my disease.

I had plenty of material and preparation. I had actively blogged about my metastatic lung cancer journey for more than a year. I had researched statistics and funding disparities. I had gleaned patient perspectives via participation in online support forums and Lung Cancer Social Media (#LCSM) tweetchats. I also had years of public speaking experience, so I wasn’t anxious about getting up in front of an auditorium full of people.

What I didn’t have was knowledge of those who typically attended Medicine X, or how best to connect with them. I had never spoken publicly about lung-cancer stigma, certainly not to an auditorium full of people unfamiliar with my disease. After MedX ePatient adviser Hugo Campos helped brainstorm ideas, I wrote a speech – but it lacked something.

To figure out what was missing, I reach out to the online lung cancer community – patients, advocates and health-care providers I knew from support groups, Facebook, and Twitter. When Chris Draft of Team Draft reviewed my speech and slides over breakfast at Denny’s during one of his trips to Seattle, he smiled tolerantly when he saw my engineer’s fascination with graphs and pie charts. Then he made a point that changed the focus of my entire presentation.

Despite the dire statistics, the public will only care about the number one cancer killer when they can see that these patients could be people they love – a parent, sibling, child, friend – or even themselves. My speech needed to show the real faces of lung cancer, he explained.

So I rewrote the entire presentation and looked for graphics that could help people connect with the patients as well as the facts. I ditched the numbers-based charts for concept-based images. Online patients provided pictures of themselves living life and doing things they enjoyed. A dozen friends from across the online lung-cancer community reviewed the pitch via email or in person. It truly became a collaborative effort.

When I stepped out on the MedX stage that September day, I brought the hopes of many in the lung-cancer community with me. Chemobrain gave me a moment of terror (I lost my place while the slides continued to change every 15 seconds) but judging from the standing ovation the ePatients gave me, I made our point. My Twitter handle was in the top ten mentioned in the #medx stream that day. Tweets from health-care providers watching the speech online and in the audience said it changed their view of lung cancer.  Lung cancer patients -smokers, non-smokers, and never smokers alike – said it expressed everything they wanted others to know about our disease. And as of today, the YouTube video (above) has been viewed more than 1,100 times. But perhaps the most gratifying reaction was when someone friended me on Facebook just to say my speech helped her forgive her father, a life-long smoker who recently died of lung cancer.

This speech represents the best of what an online community can accomplish when they collaborate. The only thing I’d change next time is to avoid delivering it in San Francisco the day before my clinical trial visit in Denver: Evidently butterflies are aggravated by PET scans.

Lung Cancer Bloggers on WEGO Health Activist Twitter Chat (11/18 at 3PM EST)

On Tuesday November 18, 2014, at 3 PM Eastern Time, the WEGO Health Activist Twitter Chat (#hachat) will focus on lung cancer in honor of Lung Cancer Awareness Month.  I will be the guest host along with three other guests, all lung cancer bloggers:  Linnea Duff (), Samantha Mixon (), and Tori Tomalia (). I’ll pose six questions to help our guests and chat participants discuss their lung cancer advocacy efforts on blogs and social media.

  • Q1: Why do you share your lung cancer journey online? What motivates you to write a post?
  • Q2: What kind of info do mbrs of online lung cancer community want? What messages do you try to convey?
  • Q3: On which social media sites do you share lung cancer info? How do you choose what info to share on different sites?
  • Q4: How/where do you find content about lung cancer that you want to share? What makes content you find share-worthy?
  • Q5: How has the lung cancer information you share changed over time?
  • Q6: What reactions do you get to your lung cancer blogs and social media posts? What content gets viewed or “liked” most?

Hope you will join us on Tuesday, whether you choose to actively participate in the chat or just watch.  Remember to include #hachat in your tweets. For more information about how to participate in a tweetchat, check out the tutorial at the #LCSM Chat website (remember to #hachat instead of #LCSM as the hashtag for this chat).

Read the Storify summary of this chat here.

My Physical Therapist Was Right (Darn It)

OK, physical therapist.  You made your point.

When I first worked with you in early 2013, about six months after cancer radiation therapy zapped the nerve bundle for my right arm (the brachial plexus), you gave me wonderful exercises to strengthen my rotator cuff muscles.  At the end my scheduled visits, you said I would have to keep doing those arm exercises daily for the rest of my life, and I shouldn’t lift more than 20 pounds with that arm, ever.

After months of daily exercises, those muscles grew strong.  I REALLY wanted to think my arm was normal again.  I thought I could be done with physical therapy and go back to lifting everyday things like kitty litter and groceries and storage boxes in the closet.

NOW, a year after our last visit, I get it.  Now, when I can’t raise my arm over my head without shoulder owies.  Now, when two sequential PET-CT scans show degeneration in the right shoulder joint. Now I’ll go back to daily arm exercises with the wimpiest exercise bands and no hand weights, like a newbie.

At least I kept the printouts of all the exercises so I know what to do.  I may take a while to get the point, but I CAN learn.

Maybe on my next flight to Denver for my clinical trial, I’ll be able to raise my right arm comfortably again.  If so, I’ll raise my arm …  and ask the flight attendant to help me by lifting my bag into the overhead bin.

Cancer reality: 20-something
Me: 1 (extra credit for keeping the exercise printouts)


A Lung Cancer ePatient Story

Last Friday, November 7, I spoke at Virginia Mason Medical Center’s Grand Rounds on the topic of “Lung Cancer in Non-Smokers.”  Grand Rounds is a common teaching tool in medical facilities that helps healthcare providers stay current and provide the best possible care.   In our one-hour session, my pulmonologist Dr. Steven Kirtland talked about the epidemiology of non-smoker lung cancer (its frequency, possible causes, patient demographics), I shared my epatient story, and my oncologist Dr. Joseph Rosales talked about lung cancer mutation testing and targeted therapies.   You can see my 20-minute presentation below.



Standing in line at Starbucks

© Janet Freeman-Daily


In Seattle, home of Starbucks, everyone drinks coffee. Can YOU tell which of them has lung cancer? In this picture, it’s the person on the far right: me.

In March 2011, I was healthy, a bit overweight, and exercising regularly. However, I’d had a nagging cough for a few months. To make my husband happy, I mentioned the cough to our doctor. Two months, two rounds of antibiotics, one x-ray, and a bronchoscopy later, I spent a very anxious four days waiting for biopsy results.

When I heard, “lung cancer,” I could barely believe the diagnosis. I called my sister to tell her the news, poured a big glass of wine, and lost myself in a favorite science fiction movie.

I had never lived with smokers, never worked in a smoking environment, never smoked anything (except a salmon). I knew nothing about lung cancer.  The facts I found online were not encouraging.  As we moved through the various staging procedures, my family and I experienced increasing levels of fear:

  • “It’s OK, it’s just one tumor. VATS surgery will probably take care of it.”
  • “Well, OK, lymph nodes are involved, but still inside one lung. We can remove the lung, right?” (OMG)
  • “There’s a lymph node between the lungs, severe inflammation and obstructive pneumonia. Stage 3a. No surgery.” This is serious. After my mediastinoscopy, my sister left the hospital convinced I was dying.

I was reassured to hear Dr, Rosales say he considered me curable. I was eager to start aggressive lung cancer treatment. But the universe, it seemed, objected to the treatment plan. The interior of my tumor had died and become colonized by bacteria. Even though we finally found an antibiotic that knocked out the infection, my recovery took weeks. During that time, I developed a clot on my PICC line and required daily self-injected blood thinner. Heaven forbid I should be a boring, vanilla cancer patient! I worried my lung cancer was growing while I waited to start treatment.

I hit bottom a few days after my second bronchoscopy. I awoke at 3 AM coughing up a lot of blood, and Dr. Kirtland told me to go to the ER.  I was released later that morning, just in time to drive 30 miles to my first radiation treatment.  The linear accelerator was down two hours for repairs, but I did eventually get zapped.  My husband and I drove to a nearby restaurant for a very late lunch, and came out to find our car had a flat tire.  Not a very reassuring start.

The next few months revolved around my daily appointments. Perhaps the toughest part was telling my autistic adopted son that he might lose another mother to cancer.  My bucket list became laser-focused on helping him prepare to live on his own.  Despite fatigue and severe esophagitis, I was able to attend my niece’s wedding a month later.  You haven’t lived until you’ve had Ahi tuna encrusted in coffee beans–pureed for a liquid diet.  At one point I was taking ten different meds to control pain and side effects.  My butt was dragging, my blood values tanked after one full dose of chemo, and I broke out in hives during my second red cell transfusion. But gradually, I started feeling better.

It all seemed worthwhile when my first post-treatment CT scan showed my lymph nodes had resolved and the primary tumor had shrunk about 90%. I wanted that tumor OUT, if possible.  I had 15 appointments in 16 days to determine if the surgery would be an acceptable risk–we only had a short window in which to do surgery before radiation changes would make it too risky.  Juggling that schedule generated a lot of additional stress —  my family’s life revolved completely around my cancer.  I wished Virginia Mason had a Lung Cancer Navigator to coordinate all the appointments between seven different professionals at four different facilities, communicate results, explain terms and options in more detail, and ensure timely follow-up.  The last procedure, a PET scan, showed a hot spot on my collarbone.  Dr. Kirtland quickly arranged an MRI scan for the next morning, and a surgical open biopsy on the following day.  To find the tiny suspicious lymph node, the surgeon used an innovative combination of FDG tracer and a Geiger counter.   Two nodes contained cancer.

Grand Rounds 4

I was now a metastatic lung cancer patient. The panic bowled me over like a 50-foot wave.  Alone at home, I became a puddle of hopelessness–for about an hour.  Then I shifted gears and got busy asking questions in an online lung cancer forum.  The support I received there was essential for maintaining hope while I processed my new diagnosis.  They helped me accept there was no point undergoing a risky lung surgery with a tough recovery when it wouldn’t cure me.

Together Dr. Rosales and I decided to start a new chemo after a couple of months, to give me time to recover from my first line treatment. I appreciated that he listened to my concerns about the delay, and that he was careful not to give me an expiration date that might take away hope. I didn’t want to die before applying for my Boeing pension, so I asked how long I had left.  Dr. Rosales estimated about two years.

In the next ten weeks, my mother died, I started taking prednisone for radiation pneumonitis, and a new three-inch tumor grew very visibly on my collarbone. My extended family gathered for what we thought might be my last Thanksgiving.  I had no desire to celebrate Christmas that year.  My most memorable gifts were a newly-installed power port and a hint that my hair was coming in curly.

In my online lung cancer forum, I learned about a clinical trial called the Lung Cancer Mutation Consortium Protocol. It tested lung cancer tumor tissue for mutations in ten different genes. I consulted with my Virginia Mason doctors, but they hadn’t heard of it.  I found the trial listing on clinicaltrials.gov, then contacted the trial sites until I found one accepting patients. The University of Colorado Cancer Center agreed to test my existing biopsy samples even though I could not fly to Denver due to concerns my hollow primary tumor might cause a pneumothorax.  My entire team was disappointed when all tests were negative.  I continued networking with experienced lung cancer patients, and when Dr. Rosales and I discussed chemo options, I suggested Avastin based on some new research.  We mutually agreed on Alimta plus Avastin–he was willing to be more aggressive in my treatment because he knew I understood the risks.

Ten days after I started the new chemo in January, my collarbone tumor was visibly shrinking. I was extremely encouraged despite a sudden worsening of my pneumonitis and my new appreciation for ‘roid rage.  Still, I was glad to finish chemo after six rounds–I was losing my voice frequently, and towards the end I felt like I always had the flu.  I began to understand how some people could decide to stop cancer treatment.  But I couldn’t argue with the results:  all the original tumors were gone, the new tumor had shrunk 90%, and no new tumors appeared. We  decided to treat this one remaining tumor as an oligo-recurrence and go for a possible cure — radiation therapy might knock my cancer out for good.  My skin burned raw, but I made it through.

The next PET scan showed no activity around my collarbone. Yay!  However…it also showed two new nodules in my “good” lung, both outside the radiation field.  Seems I progress whenever I stop chemo.  Another bronchoscopy was scheduled two weeks out, after my husband and I returned from a weekend with my nephew in Denver.

Grand Rounds 5

© University of Colorado Cancer Center (used with permission)


Here’s where the tone of my story changes.

Months before, one of my online lung cancer friends told me of a new mutation called ROS1. I fit the profile of typical patients who had it, and a Phase 1 ROS1 trial still had slots left, but only a lab in Boston could test for it. No one at Virginia Mason knew about it.  On my last full day in Denver, I realized the University of Colorado Cancer Center was not far from my nephew’s house.  I might be able to personally thank the people who had helped me get my previous mutation testing done. I sent an email Sunday afternoon, and was amazed to get an email back that evening saying I could meet the next day with Dr. Bunn, the Center’s Director. He told me they could now test for additional mutations, including ROS1. I gave him permission to test my remaining slides.

A week later, Dr. Kirtland performed a bronchoscopy on the larger of my new nodules. He got a good sample, but couldn’t find any cancer cells. The biopsied nodule could be inflammation, BOOP, or cancer. The other nodule was too small to biopsy.

The very next day, Dr. Bunn emailed me to say I had “an impressive ROS1 rearrangement” and University of Colorado had an opening in a crizotinib trial for me, if I wanted it. Crizotinib is a twice-daily pill that targets cells expressing certain mutations, including ROS1. It produced a terrific response rate in the initial trial with substantially fewer side effects than chemo for most patients. He also said I could join the trial later if I didn’t have active cancer now. I was so excited that I almost screwed up forwarding the email to Dr. Rosales.

The following morning, Dr. Rosales called, also excited by my ROS1 news. If the new nodule was cancer, he agreed I should enter the ROS1 trial rather than start taking Alimta.

That afternoon, Dr. Kirtland called. He had taken my case to the Tumor Board, and their consensus said the biopsied nodule was radiation changes. I was to restart prednisone.  (My husband asked, “What will he give ME when YOU restart steroids?”)  In a month I would have a CT to determine if the nodules responded to prednisone, or continued growing.  I’d come to accept that living with stage IV lung cancer brought uncertainties, but that didn’t make the waiting easier.

The CT scan showed the larger nodule had not changed, but the smaller nodule had grown nearly fifty percent. The good news was that I could once again ramp down off prednisone.  The bad news was that the smaller nodule was likely cancer–I needed to either restart Alimta, or join the crizotinib trial.

Grand Rounds 6

I was on the phone the next morning to the University of Colorado, inquiring about how to join the ROS1 trial. Their doctors said I might be able to join the trial without having another biopsy.  Virginia Mason medical records and radiology really hustled to pull my records together.  After four days, I was flying to Denver with the intention of staying until I was accepted into the trial, and wondering why the heck I was traveling a thousand miles away from my home and family to try an experimental cancer treatment that might not work.  My concerns were not eased by the delays caused by Hurricane Sandy, which shut down the trial sponsor Pfizer’s headquarters in New York City during my screening period.  My acceptance into the trial came at the last possible minute.

I took my first crizotinib pill two years ago last Thursday. My first scan eight weeks later showed both nodules were gone, indicating they likely were both cancer.  As of last Monday’s scan, I have had No Evidence of Disease (known to cancer patients as “NED”) for 22 months and counting. I may be able to stay on this drug for months or years longer. Yet targeted therapies like the one I take do not offer a permanent cure. In time I’ll probably develop resistance to the drug.  There IS no cure for metastatic lung cancer.  No one can say how long I will live.  Sometimes that weirds me out.  Yet I’m hopeful that when this trial drug stops working, another clinical trial will be a good match for me.

Grand Rounds 7

It’s an odd existence, living from scan to scan in eight-week increments. I still sometimes experience scanxiety, as we patients call it.  I often hide out in the bedroom for days before a scan so my scanxiety doesn’t bite anyone.  There is no logical reason for this feeling.  My scans have been clean for months, and I have no symptoms that would indicate the next scan should be any different.  If I do have a recurrence, I know I have some treatment options.  Even if I had no treatment options, I am not afraid of dying.  Apparently my subconscious simply overpowers my conscious positive thoughts.  It probably doesn’t help that whenever I’m leaving for a scan, my son hugs me hard and says, “Please don’t die Please don’t die Please don’t die.”

Several events conspired to give me severe scanxiety a year ago. It felt like a panic attack. Not only was the timing near the anniversaries of my two cancer recurrences, but a friend on a targeted therapy had developed brain mets weeks after a brain MRI, a neighbor had died when her lung cancer spread to her brain covering, and the online ROS1 buddy who had first told me about my clinical trial appeared to be progressing after two years on crizotinib.  A network of lung cancer patients provides invaluable support, but it requires accepting that friends will die frequently.

Grand Rounds 8

I feel overwhelmingly grateful for everything and everyone that has helped me survive as long as I have: medical science that discovered new ways to treat my condition, compassionate healthcare providers at Virginia Mason and in Denver, insurance that paid for most of my care, family and friends who supported me, a knowledgeable online lung cancer community, and all the prayers and good wishes lifting me up throughout my cancer journey.  I’m acutely aware that many lung cancer patients do not have these supports and opportunities.

Being given a second chance at life, however long it might be, tends to give one a different perspective. Seeing the sunset paint Mount Rainier fills my heart.  Chatting with my sister over a latte keeps me smiling for a week.

A second chance at life also makes one introspective. Why was I spared when others died?  Why does my mutation have an effective treatment when others don’t? Why am I able to see one of the best lung cancer doctors in the world when many patients can’t afford proper treatment? Why am I still here?

I had been blessed with gifts that helped me survive my cancer journey thus far. In my previous career of aerospace engineering, I was a “translator” of sorts: I researched science and technology developments and helped others understand their benefits.  Thanks to these skills,  I’m able to understand lung cancer treatments and research. I’m able to explain what I’ve learned, both verbally and in writing, in everyday terms. And I’m able to advocate for myself with healthcare providers.

I have chosen to use these gifts to help other lung cancer patients by going public with my lung cancer in my blog, in online forums, and in public speaking.  Most patients don’t know about the new treatments like the one I’m taking–even some doctors don’t know. Lung cancer patients need more than compassion. They need information about second opinions, mutation testing, side effects, treatment options, and clinical trials.  They need HOPE.

Lung cancer people     Breast Cancer People

Going public has also helped more people understand that ANYONE with lungs can get lung cancer—and NO ONE deserves to die from it. Lung cancer kills about as many people as the other top four cancers combined, yet it receives fewer federal research dollars per death than any of them.  Why is that?  Are lung cancer patients not worth saving?  The answer becomes clear when you google the words “lung cancer people.” No throngs of ribboned supporters; few smiling survivors.  You see diseased lungs, death … and smoking.  Lung cancer has an image problem.  The first question I hear when I mention my disease is: “Did you smoke?” People blame patients for getting lung cancer. The breast cancer community has changed how the world sees their disease. The lung cancer community must do the same.  We’ve all done things that impact our health.  Yes, it’s healthier not to smoke.  But it’s not a sin that warrants the death penalty.

puffy feet

© Janet Freeman-Daily


Precision medicine allows me to live with lung cancer as a chronic illness instead of a death sentence. True, it’s not the same life I had Before Cancer. I can’t do the active sports that I used to do.  Chemotherapy left me with peripheral neuropathy and cognitive changes.  Radiation scarred my lungs and damaged the nerve bundle for my right arm. A year of steroids packed on the fat while decreasing muscle tone.  Crizotinib causes edema and graces me with antisocial gut behaviors. Some combination of side effects keeps my red blood cell count just below normal. When I exercise on the treadmill, I can’t get manage a brisk walk for more than 30 seconds without breathing fast and hard.

Image Credit: Stephanie Jarstad

Image Credit: Stephanie Jarstad

I’m not complaining, mind you–I’m happy to be alive and have a relatively normal life on targeted therapy. It even allowed me to play a casual game of softball in Cheney Stadium at my 40th high school reunion. The moment I put the glove on my left hand, my body recalled those years on the softball diamond. After some initial fumbles, I could catch, throw, pitch and hit. And I got to first base before the ball did.  I could not have even reached first base while on chemo.

As a three-year lung cancer survivor, I’ve already lived beyond my prognosis. I will stay with targeted therapy and other clinical trials as long as my quality of life makes it worthwhile. Lung cancer research has found more new treatments in the past few years than ever before, and the pace of discoveries is accelerating.  As people begin to realize that ANYONE can get lung cancer (including never smokers like me), the stigma will hopefully begin to fade, and research funding will increase.

We lung cancer patients deserve hope, and a cure. Every one of us.

Special #LCSM Chat Topic 11/05 1 PM ET: @TheNCI hosts chat on precision medicine in lung cancer

This is a repost of a blog on the #LCSM Chat website (posted with permission):


#LCSM Chat is pleased to announce a special #LCSM Chat for Lung Cancer Awareness Month will be held on WEDNESDAY, November 5 at 1 PM Eastern Time (NOT our usual day and time). The National Cancer Institute (@theNCI) and a panel of experts will be using the #LCSM hashtag to talk about exciting new lung cancer treatment options!

This chat will be in question-and-answer format, with a panel of experts addressing specific topics posed by @theNCI as well as fielding audience questions related to those topics. This format is great for patients, caregivers, medical personnel and advocates regardless of their previous experience with tweetchats.  We hope you’ll join us!  (Check out our refresher on how to join a tweetchat)

Below is NCI’s announcement about the November 5 Chat.

On Wednesday, November 5 from 1:00-2:00 ET, the National Cancer Institute (@theNCI) will be hosting a Twitter chat on precision medicine in lung cancer using the #LCSM hashtag.

We’ll have a “who’s who” of precision medicine lung cancer experts on the chat, including:

  • Dr. David Gerber, Lung Cancer Specialist, UT Southwestern Medical Center
  • Ryan M. Hohman, JD, Managing Director, Policy & Public Affairs, Friends of Cancer Research
  • Dr. Shakun Malik, Head, Thoracic Cancer Therapeutics in the Clinical Investigations Branch of the Cancer Therapy Evaluation program at the National Cancer Institute
  • Dr. Geoffrey R. Oxnard, MS, Instructor in Medicine, Harvard Medical School
  • Dr. Vassiliki Papadimitrakopoulou, M.D., Professor, Department of Thoracic/Head and Neck Medical Oncology, at the University of Texas MD Anderson Cancer Center, Houston, TX

During the chat, the experts will be discussing, among other topics, how lung cancer treatment has changed over the last few years, provide more information about the definition of “precision medicine” as it applies to lung cancer, discuss when patients might consider a clinical trial, as well as provide more background and specifics on the Lung-MAP and ALCHEMIST clinical trials.

For more background information on Lung-MAP, we also recommend Friends of Cancer Research’s “What Leaders in the Field are Saying About Lung-MAP.”

Technology for Coordinating Care — #hcldr chat 10/28

Lung cancer and other acute/chronic health conditions require care teams with more than one healthcare professional, sometimes located in more than one care facility.  To provide the best care for the patient, these teams often must coordinate with the patient as well as caregivers, family members, care facilities, and community services.  How can technology platforms (like smart phones and social media) help with this process?

#HCLDR Chat will tackle this topic, Platforms for Community-Wide Care Coordination, in their next chat on Tuesday, October 28, at 8:30 PM Eastern Time.

I hope you’ll join the #hcldr chat and share YOUR thoughts on this important subject.  We’ll be discussing the following topics:

  • T1: What are the most important challenges patients, family members & caregivers face in coordinating care?
  • T2: What challenges do care teams (clinicians, lay health workers, managers) face in coordinating care?
  • T3: What are examples of where social media and other technologies have supported care coordination?
  • T4: How can social media & other technologies help coordinate care for publicly insured, rural & other underserved communities?

I (@JFreemanDaily) will be participating as a guest in this chat, along with other members of a panel who will be presenting at the upcoming Workshop on Interactive Systems in Healthcare (WISH) 2014 which will be co-located with the American Medical Informatics Association (AMIA) Annual Symposium on November 15, 2014 in Washington, DC.   The responses gathered in the #hcldr chat will be included in our WISH panel discussion.  The other panelists participating in the chat are:

  • Katherine Kim, PhD, MPH, MBA (@kimkater): health informaticist, researcher and Assistant Professor at University of California, Davis
  • Charles Boicey, MS, RN-BC, CPHIMS (@N2InformaticsRN): Enterprise Analytics Architect for the State University of New York, Stony Brook Medicine
  • Susan Hull, MSN, RN (@SusanCHull): nursing executive , founder and CEO of WellSpring Consulting
  • Anna McCollister-Slipp (@annamcslipp): diabetes epatient, co-founder of Galileo Analytics

My Take on This

This is a topic of great interest to me.  I can see many care coordination needs that might be addressed with technology platforms.  Here are some snippets from my own experience as a lung cancer patient.

Having multiple care providers at different facilities is a common situation with lung cancer.  When I was undergoing my first line of treatment, I met regularly with seven healthcare providers in four different facilities:  a pulmonologist and infectious disease doctor in a major medical center, a medical oncologist and infusion nurse in a local clinic, a  radiation oncologist and nurse in a different local clinic, and a contractor that provided supplies for my PICC line.  Even though the doctors all belonged to the same medical center, each facility had different scheduling software and limited or no access to my electronic medical records at the other facilities.  Care coordination was mostly done by telephone and fax.  My husband and I tracked my daily appointments on a wall calendar at home.  If the infusion nurse giving me my chemo needed to ask a question of the radiation oncology nurse who has seen me when I received my radiation treatment 30 minutes earlier, they played phone tag in between patients.  Having a common platform accessible to all team members that showed my appointment schedule and treatment notes and allowed even brief instant messaging (e.g., “give Janet 1L IV fluids after her chemo today”) would have been very helpful.

Having a device that could display my current health conditions and meds, then connect an emergency medical tech or doctor to my oncologist (even when out of cell phone range) would be pretty nifty.  Currently I keep a two-page summary of my lung cancer treatment history and contact info with me on a USB Medic Alert bracelet when I travel.  This presumes whoever finds me unconscious has a PC with a USB port and a PDF reader handy. My epatient friend Casey Quinlan had her medical record access info tattooed as a QR code on her chest.

I have learned the value of keeping a complete set of my medical records at home in case I need them.  While I can access some of my medical records online at the two medical centers where I currently receive care, right now I can only see lab results, and (at one facility) scan reports.  When my tumor tissue underwent mutation testing at an NCCN facility, an oncologist’s office at the same facility couldn’t find the test results without my sleuthing to find a specific number on a faxed copy of the test report–fortunately I had requested one previously.  There’s GOT to be a better way to transmit current medical records rapidly between facilities than faxing or emailing scanned documents!

Metastatic lung cancer patients like me–especially those who are eligible for targeted therapies, aggressive treatment, or clinical trials–find second opinions can be life saving.  When a patient takes a turn for the worse or a clinical trial has limited openings, the second opinion may occur on short notice.  For me, pursuing a second opinion for my lung cancer today would mean going to a 3-foot-deep file cabinet drawer and gathering a stack of CDs containing relevant CT, PET, and MRI scans and other medical records (clinic notes, pathology reports, lab results, chemo summaries, radiation treatment summaries, etc).   If I were to include all the records I’ve generated in over three years of lung cancer treatment, the stack of CDs would be over 4 inches thick.  The radiology scan files are too big to be transmitted electronically and still preserve the ability to view the data, so I’d take those CDs with me.  All those other records provided by my care center exist as a few unsearchable pdf files containing hundreds of images of hardcopy documents.   For those records, I’d save the second opinion doc from having to read every single page of the huge file; instead, I’d ask which files they need to see, and print hardcopies to take instead (I keep the most important of these in a 3-ring binder).  If I had a week, I could request CDs of the specific files from the medical records department and wait to receive them via snailmail.

Some patients may use medical devices such as my CPAP machine that generate medical data useful to the care team.  However, it may be difficult or impossible to pass that data to a healthcare provider in a different location, or even access the data if the device employs proprietary designs.  My CPAP has a removable SD disk that can be read by most card readers in PCs.  However, I’d have to download the software to read it, and I can’t capture the data I read so I can transmit it to anyone.  “Interoperability” doesn’t really exist with medical devices yet.  I may be hallucinating from too much chocolate, but I’d love to see a platform that provides an interface to different medical devices and electronic medical records so they can network the way my Fitbit shares data with my LoseIt! diet app on my smartphone.

I’d also love to see care coordination solutions designed for those who do not have reliable access to the Internet.  Not all patients live in areas where broadband Internet or cell phone coverage is available, and not all patients can afford to pay for Internet service or devices that access it.  Yes, they could go to the library, but who wants to put sensitive personal medical info on a screen and unsecure computer for everyone to read?

Speaking as a system engineer, creating a secure technology platform that meets all the requirements and desirements without causing more complications in the already messy digital medicine world will require out-of-the-box creativity.  Maintaining data security and HIPPA privacy is essential.  Forcing already overloaded healthcare workers to use yet another interface, or forcing facilities to invest in a new standardized medical records system without providing the funds and training to implement it, are both non-starters.  The motivation for change will have to come from demonstrating that a new technology platform improves care quality and access, reduces cost and workload, and is readily adopted by patients and carers alike.

The first step in solving this problem is to capture the requirements; I hope the #hcldr chat on 10/28 will contribute to this effort.

Care Coordination Challenge graphic (UC Davis)
Image credit: UC Davis Betty Irene Moore School of Nursing